Neurovascular Devices Market by Product (Embolization Devices, Revascularization Devices, Embolic Protection Devices, and Accessory Devices), Disease Pathology (Aneurysm, Arteriovenous Malformation (AVM), Ischemic Stroke, Stenosis, and Others): Global Opportunity Analysis and Industry Forecast, 20202027
- Published Date: 2020-11-26
- Report ID: 21690
- Pages: 250
-
Format:
The neurovascular devices market accounted for $2,935 million in 2019, and is expected to reach $3,712 million by 2027, registering a CAGR of 5.2% from 2020 to 2027.
Neurovascular devices are defined as instruments and machines employed in treatment of various neurovascular disorders. Furthermore, neurovascular disorders include medical conditions that affect blood vessels, which supply the brain and spinal cord with oxygenated blood. Thus, neurovascular devices such as embolization devices, revascularization devices, thrombectomy devices, and embolic protection devices are used in treatment of neurovascular disorders.
These devices are used in disorders such as aneurysm. For instance, embolization devices are used in occlusion of blood vessels to reduce blood flow, which, in turn, aids in reduction of blood flow. Similarly, other neurovascular devices such as thrombectomy devices are used in disorders such as ischemic stroke. For instance, these thrombectomy devices aid in recovering the brain from ischemic condition if it has not attained the stage of complete infarction. Thus, these devices restore perfusion through blocked artery.
The major factor that contributes toward growth of the neurovascular devices market include surge in geriatric population. Furthermore, other factors such as rise in prevalence of neurovascular diseases and surge in adoption of neurovascular devices across the globe also contribute to growth of the market. In addition, factors such as surge in technological advancements related to neurovascular devices also boost growth of the neurovascular devices market.
However, high cost of neurovascular devices and dearth of qualified neurosurgeons required to handle these devices restrict growth of the market. Conversely, high growth rate exhibited by developing nations provides lucrative opportunities for players operating in the neurovascular devices market
The global neurovascular devices market is segmented on the basis of product, disease pathology, and region to provide a detailed assessment of the market. By product, the market is divided into embolization devices, revascularization device, thrombectomy devices, embolic protection devices, and accessory devices.
Moreover, these product categories are further divided into sub segments for a profound understanding. For instance, the embolization devices segment is divided into clippings, embolic coils, coil assist stents, and coil assist balloons. In addition, the embolic coils segment is further divided into bare detachable coils and coated detachable coils.
The revascularization device segment is further divided into carotid artery stents and flow diversion stents. In addition, the thrombectomy devices segment is divided into clot retrieval devices, suction & aspiration devices, and snares. The embolic protection devices segment is divided in distal filter devices and balloon occlusion devices. Similarly, the accessory devices segment is divided into microcatheters, and micro guidewires. By disease pathology, the market is classified into aneurysm, arteriovenous malformation (AVM), stenosis, ischemic stroke and others. By region, the neurovascular devices market size is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The major players in the neurovascular devices market are Medtronic Plc, Stryker Corporation, Penumbra, Inc., Johnson & Johnson, Terumo Corporation, Merit Medical Systems, Inc.., Integer Holdings Corporation, Acandis GmbH., W. L. Gore & Associates, Inc., and Microport Scientific Corporation.
KEY BENEFITS FOR STAKEHOLDERS
This report entails a detailed quantitative analysis along with the current global neurovascular devices market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessments.
The market size and estimations are based on a comprehensive analysis of key developments in the industry.
A qualitative analysis based on innovative products facilitates strategic business planning.
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
Key Market Segments
By Product
o Embolization Devices
Clippings
Embolic Coils
Bare Detachable Coils
Coated Detachable Coils
Coil Assist Stent
Coil Assist Balloon
o Revascularization Devices
Carotid Artery Stents
Flow Diversion Stents
o Thrombectomy Devices
Clot Retrieval Devices
Suction & Aspiration Devices
Snares
o Embolic Protection Devices
Distal Filter Devices
Balloon Occlusion Devices
o Accessory Devices
Microcatheters
Micro-guidewires
By Disease Pathology
o Aneurysm
o Arteriovenous Malformation and Fistulas (AVM)
o Ischemic Stroke
o Stenosis
o Others
By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
UK
Italy
Spain
Rest of Europe
o Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
o LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
List of key players profiled in the report:
Medtronic Plc,
Stryker Corporation
Penumbra, Inc.
Johnson & Johnson
Terumo Corporation
Merit Medical Systems, Inc.
Integer Holdings Corporation
Acandis GmbH
W. L. Gore & Associates, Inc.
Microport Scientific Corporation
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
Asahi Intecc co., ltd.
Kaneka Medix Corp.
Embolx, Inc.
Wallaby Medical
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.2.1.List of key players profiled in the report
1.3.Research methodology
1.3.1.Primary research
1.3.2.Secondary research
1.3.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top Wining Strategies
3.2.2.Top investment pockets
3.3.Market share analysis, 2019
3.4.Key forces shaping neurovascular devices industry/market
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Surge in geriatric population across the globe
3.5.1.2.Rise in prevalence of neurovascular diseases
3.5.1.3.Increase in prevalence of underlying disease conditions serve as risk neurovascular diseases.
3.5.1.4.Technological advancements related to neurovascular devices
3.5.2.Restraints
3.5.2.1.High cost of neurovascular devices
3.5.2.2.Dearth of neurosurgeons across the globe
3.5.3.Opportunity
3.5.3.1.Opportunities in emerging markets
3.5.4.Impact Analyses
CHAPTER 4:NEUROVASCULAR DEVICES MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Embolization Devices
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by type
4.2.2.1.Clippings
4.2.2.1.1.Market size and forecast
4.2.2.2.Embolic Coils
4.2.2.2.1.Market size and forecast
4.2.2.2.2.Bare Detachable Coils
4.2.2.2.2.1.Market size and forecast
4.2.2.2.3.Coated Detachable Coil
4.2.2.2.3.1.Market size and forecast
4.2.2.3.Coil assist stent
4.2.2.3.1.Market size and forecast
4.2.2.4.Coil assist balloon
4.2.2.4.1.Market size and forecast
4.2.3.Market size and forecast, by region
4.2.4.Market analysis, by country
4.3.Revascularization Devices
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by type
4.3.2.1.Carotid artery stents
4.3.2.1.1.Market size and forecast
4.3.2.2.Flow diversion stents
4.3.2.2.1.Market size and forecast
4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country
4.4.Thrombectomy Devices
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by type
4.4.2.1.Clot Retrieval Devices
4.4.2.1.1.Market size and forecast
4.4.2.2.Suction and Aspiration Devices
4.4.2.2.1.Market size and forecast
4.4.2.3.Snares
4.4.2.3.1.Market size and forecast
4.4.3.Market size and forecast, by region
4.4.4.Market analysis, by country
4.5.Embolic Protection Devices
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by type
4.5.2.1.Distal filter devices
4.5.2.1.1.Market size and forecast
4.5.2.2.Balloon Occlusion Devices
4.5.2.2.1.Market size and forecast
4.5.3.Market size and forecast, by region
4.5.4.Market analysis, by country
4.6.Accessory Devices
4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by type
4.6.2.1.Microcatheters
4.6.2.1.1.Market size and forecast
4.6.2.2.Microguidewires
4.6.2.2.1.Market size and forecast
4.6.3.Market size and forecast, by region
4.6.4.Market analysis, by country
CHAPTER 5:NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY
5.1.Overview
5.1.1.Market size and forecast
5.2.Aneurysm
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Arteriovenous Malformation (AVM)
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Ischemic stroke
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.5.Stenosis
5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
5.6.Others
5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country
CHAPTER 6:NEUROVASCULAR DEVICES MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends and opportunities
6.2.2.Market analysis, by country
6.2.2.1.U.S.
6.2.2.1.1.U.S. market size and forecast, by product
6.2.2.1.2.U.S. market size and forecast, by disease pathology
6.2.2.2.Canada
6.2.2.2.1.Canada market size and forecast, by product
6.2.2.2.2.Canada market size and forecast, by disease pathology
6.2.2.3.Mexico
6.2.2.3.1.Mexico market size and forecast, by product
6.2.2.3.2.Mexico market size and forecast, by disease pathology
6.2.3.North America market size and forecast, by product
6.2.4.North America market size and forecast, by disease pathology
6.3.Europe
6.3.1.Key market trends and opportunities
6.3.2.Market analysis, by country
6.3.2.1.Germany
6.3.2.1.1.Germany market size and forecast, by product
6.3.2.1.2.Germany market size and forecast, by disease pathology
6.3.2.2.France
6.3.2.2.1.France market size and forecast, by product
6.3.2.2.2.France market size and forecast, by disease pathology
6.3.2.3.UK
6.3.2.3.1.UK market size and forecast, by product
6.3.2.3.2.UK market size and forecast, by disease pathology
6.3.2.4.Italy
6.3.2.4.1.Italy market size and forecast, by product
6.3.2.4.2.Italy market size and forecast, by disease pathology
6.3.2.5.Spain
6.3.2.5.1.Spain market size and forecast, by product
6.3.2.5.2.Spain market size and forecast, by disease pathology
6.3.2.6.Rest of Europe
6.3.2.6.1.Rest of Europe market size and forecast, by product
6.3.2.6.2.Rest of Europe market size and forecast, by disease pathology
6.3.3.Europe market size and forecast, by product
6.3.4.Europe market size and forecast, by disease pathology
6.4.Asia-Pacific
6.4.1.Key market trends and opportunities
6.4.2.Market analysis, by country
6.4.2.1.Japan
6.4.2.1.1.Japan market size and forecast, by product
6.4.2.1.2.Japan market size and forecast, by disease pathology
6.4.2.2.China
6.4.2.2.1.China market size and forecast, by product
6.4.2.2.2.China market size and forecast, by disease pathology
6.4.2.3.Australia
6.4.2.3.1.Australia market size and forecast, by product
6.4.2.3.2.Australia market size and forecast, by disease pathology
6.4.2.4.India
6.4.2.4.1.India market size and forecast, by product
6.4.2.4.2.India market size and forecast, by disease pathology
6.4.2.5.South Korea
6.4.2.5.1.South Korea market size and forecast, by product
6.4.2.5.2.South Korea market size and forecast, by disease pathology
6.4.2.6.Rest of Asia-Pacific
6.4.2.6.1.Rest of Asia-Pacific market size and forecast, by product
6.4.2.6.2.Rest of Asia-Pacific market size and forecast, by disease pathology
6.4.3.Asia-Pacific market size and forecast, by product
6.4.4.Asia-Pacific market size and forecast, by disease pathology
6.5.LAMEA
6.5.1.Key market trends and opportunities
6.5.2.Market analysis, by country
6.5.2.1.Brazil
6.5.2.1.1.Brazil market size and forecast, by product
6.5.2.1.2.Brazil market size and forecast, by disease pathology
6.5.2.2.Saudi Arabia
6.5.2.2.1.Saudi Arabia market size and forecast, by product
6.5.2.2.2.Saudi Arabia market size and forecast, by disease pathology
6.5.2.3.South Africa
6.5.2.3.1.South Africa market size and forecast, by product
6.5.2.3.2.South Africa market size and forecast, by disease pathology
6.5.2.4.Rest of LAMEA
6.5.2.4.1.Rest of LAMEA market size and forecast, by product
6.5.2.4.2.Rest of LAMEA market size and forecast, by disease pathology
6.5.3.LAMEA market size and forecast, by product
6.5.4.LAMEA market size and forecast, by disease pathology
CHAPTER 7:COMPANY PROFILES
7.1.ACANDIS GmbH
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Product portfolio
7.1.4.Key strategic moves and developments
7.2.B. BRAUN MELSUNGEN AG
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.3.INTEGER HOLDINGS CORPORATION
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments
7.4.JOHNSON & JOHNSON (CERENOVUS)
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments
7.5.MICROPORT SCIENTIFIC CORPORATION
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.6.MEDTRONIC PLC.
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.6.6.Key strategic moves and developments
7.7.PENUMBRA, INC.
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance
7.8.PHENOX GmbH
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Key strategic moves and developments
7.9.STRYKER CORPORATION
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.9.6.Key strategic moves and developments
7.10.TERUMO CORPORATION (MICROVENTION, INC.)
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
7.10.6.Key strategic moves and developments
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
